Latest news with #NutexHealthInc
Yahoo
03-06-2025
- Business
- Yahoo
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
HOUSTON, June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2025 annual meeting to be held on July 14, 2025 at 10:00 am Central Time via the internet as a virtual meeting only (and not in person) at We look forward to hosting you at our virtual shareholder meeting and encourage you to participate and vote. Commencing June 2, 2025, we are mailing the Notice of Internet Availability of Proxy Materials, as specified below. For its 2025 Annual Meeting, the Company has chosen to use the "notice only" option for the delivery of proxy materials. This means that at least 40 days before the annual meeting date, we are mailing the notice to you or your bank, broker, trustee or other intermediary and then your bank, broker, trustee or other intermediary will mail to you such "Notice Regarding the Availability of Proxy Materials." The notice contains important information about accessing the annual meeting proxy materials and voting your shares. The Company's stockholders will not receive a paper set of annual meeting proxy materials, unless they request the proxy materials in paper form using the instructions printed on the notice. Stockholders may view our definitive proxy statement dated June 2, 2025 and our Form 10-K online OR may receive a free paper or email copy of the material(s) by following the instructions in their notice. As specified in the notice, if a stockholder of the Company would like to request a copy of the material(s) for the Company's 2025 Annual Meeting, the stockholder may (1) visit (2) call 1-800-579-1639 or (3) send an email to sendmaterial@ If sending an email, the stockholder must include the control number that is indicated in the notice in the subject line. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent Quarterly Report on Form 10-Q for the three months ended March 31, 2025 under the heading "Risk Factors" in Part II, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View original content: SOURCE Nutex Health, Inc. Sign in to access your portfolio
Yahoo
22-05-2025
- Business
- Yahoo
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
HOUSTON, May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the Company. The decision to change auditors was not as a result of any disagreement between the Company and CBIZ on any matter of accounting principles or practices, financial statement disclosure, auditing scope or procedures. The Company is working closely with CBIZ and Grant Thornton to ensure a seamless transition. "Building on our great momentum and steadily increasing market cap, and also as part of the Company's commitment to best corporate governance practices, our Board of Directors believed it was a good time to change auditors. We would like to extend our gratitude to CBIZ for their expertise and quality audit services provided to the Company over many years," stated Jon Bates, Chief Financial Officer of Nutex Health. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View original content: SOURCE Nutex Health, Inc.
Yahoo
15-05-2025
- Business
- Yahoo
Nutex Health Inc (NUTX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ...
Release Date: May 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Nutex Health Inc (NASDAQ:NUTX) reported a significant increase in total revenue for Q1 2025, reaching $211.8 million, a 214% increase from the previous year. The company achieved a 20.5% increase in total patient visits, indicating strong demand for its services. Net income attributable to Nutex Health Inc (NASDAQ:NUTX) was $14.6 million, a substantial improvement from a loss in the previous year. The arbitration process has been successful, with an 80% win rate, leading to increased facility collections by 200-300% compared to initial insurance payments. Nutex Health Inc (NASDAQ:NUTX) plans to open three additional hospitals in 2025, expanding its microhospital model in high-demand markets. The arbitration process, while beneficial, involves high monetary costs and extended time to receive payments, which could impact cash flow. Despite improvements, the company is not yet at a steady state with its arbitration process, indicating potential volatility in future quarters. Labor costs increased by 29%, driven by higher volumes and the opening of new hospitals, which could pressure margins. The company faces challenges in expanding its hospital network due to the time-intensive nature of building new facilities from the ground up. There is no current penalty for insurance companies that delay payments, which could affect the timeliness of revenue realization. Warning! GuruFocus has detected 8 Warning Signs with NUTX. Q: Can you provide more clarity on the arbitration process and its impact on cash flow? A: John Bates, CFO, explained that while they are still in the early stages of the arbitration process, they are beginning to see more predictable patterns. The reimbursement rates have shown improvement, and while they are not yet at a steady state, the trend is positive. The company expects further clarity as they continue to gather data over the next few quarters. Q: With the cash reserves growing, what are your plans for capital deployment? A: Tom Vo, CEO, mentioned that they are considering several options, including opening new hospitals, investing in population health, and potentially acquiring smaller hospitals. They are also considering shareholder returns through dividends or share buybacks, but the focus remains on maximizing shareholder value. Q: How is the addition of new arbitrators expected to impact the arbitration process? A: John Bates, CFO, noted that the addition of new arbitrators is expected to help alleviate the backlog in the arbitration process. This should improve the timeliness of payments and overall efficiency, which is beneficial for the company. Q: Are you operating at a steady run rate in terms of acuity mix and inpatient volume? A: Tom Vo, CEO, and Josh Deilio, COO, indicated that while they have room to grow in inpatient capacity, they are adding specialists to manage more complex cases. They expect continued growth in acuity and inpatient volumes as they enhance their capabilities. Q: Is there a penalty payment included in arbitration settlements, and how might this affect future revenue comparisons? A: John Bates, CFO, clarified that currently, there is no penalty for late payments in arbitration settlements. However, proposed legislation could introduce penalties, which would improve payment timeliness. This change could impact future revenue comparisons if implemented. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-04-2025
- Business
- Yahoo
Why Nutex Health Inc. (NUTX) is Surging in 2025
We recently published a list of . In this article, we are going to take a look at where Nutex Health Inc. (NASDAQ:NUTX) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year. Healthcare spending has been continuously soaring and is projected to do so in the coming years due to demographic tailwinds. The industry now accounts for a fifth of the U.S. economy, and it's a good idea to have exposure to it. Most executives now hold a favorable view of the industry's prospects, a notable increase from 52% just a year ago. Moreover, it's an industry that is more insulated from tariffs and macro risks. Of course, the top gainers here are not defensive healthcare stocks, but it's still worth looking into the winners here if you are chasing potential multibaggers. Even during bear markets, there are pockets of the market that perform exceptionally well. For example, I identified in another article. For this article, I screened the best-performing healthcare stocks year-to-date. I will also mention the number of hedge fund investors in these stocks. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A medical professional in scrubs providing care to a patient. Number of Hedge Fund Holders In Q4 2024: 6 Nutex Health Inc. (NASDAQ:NUTX) is a physician-led healthcare services company operating micro-hospitals, population health management, and real estate segments across the United States. The stock is up significantly so far in 2025 after the fourth-quarter and full-year 2024 earnings report, released in late March 2025, which showed total revenue nearly doubling to $479.9 million and net income swinging to $52.2 million from a $45.8 million loss the prior year. Adjusted EBITDA jumped over 1,000% to $123.7 million, and the hospital division saw visits rise by 17%. A key driver behind this explosive growth was Nutex Health Inc. (NASDAQ:NUTX)'s strategic shift in mid-2024 to aggressively pursue arbitration under the No Surprises Act for out-of-network claims. This resulted in much higher reimbursement rates per visit and an over 80% success rate in claims. The consensus price target of $80 implies 35.24% downside. Nutex Health Inc. (NASDAQ:NUTX) stock is up 289.84% year-to-date. Overall, NUTX ranks 4th on our list of healthcare stocks that are surging in 2025. While we acknowledge the potential of NUTX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than NUTX but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
21-04-2025
- Business
- Yahoo
Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout
We recently published a list of . In this article, we are going to take a look at where Nutex Health Inc. (NASDAQ:NUTX) stands against other most expensive stocks insiders are buying after Trump's tariff rollout. Wall Street banks have sharply cut their targets for the broader market index due to growing fears about the economic fallout from new tariffs, writes the Financial Times. Since the tariff announcement on April 2, the broader market index has dropped nearly 7%. Major banks now expect lower market gains in 2025, with some analysts predicting a possible bear market directly triggered by presidential policy shifts. Amid tariff wars and market uncertainty, insider trading often draws attention. Insider stock purchases may signal executive confidence, while sales aren't necessarily negative—they could reflect personal or diversification choices. It's best to view insider trading in context with a company's financials and market conditions. Today, we're highlighting most expensive stocks that insiders have been buying in April. Using Insider Monkey's trading screener, we looked for companies with share prices of at least $30 and insider purchases between April 2 and April 21. From there, we ranked the top 12 stocks based on the highest average purchase price per share. Stocks that were recently covered were excluded from this list. Most of those can be seen on this list of the 19 mid- and large-cap stocks insiders are buying after Trump's tariff rollout. Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A medical professional in scrubs providing care to a patient. Nutex Health Inc. (NASDAQ:NUTX) is a physician-led healthcare services and operations company based in Houston, Texas. It operates through three segments: Hospital, Population Health Management, and Real Estate, offering services like 24/7 emergency and inpatient care, imaging, labs, and pharmacy support. The company also manages physician groups, runs a cloud-based healthcare platform, and owns hospital properties across the U.S. On April 8, the company's CFO Christian Jon Bates purchased around $81,810 worth of Nutex Health shares at an average price of $81.81 per share. Year-to-date, the stock gained 370.18% and is now trading at $149 per share. Over the past 12 months, Nutex Health returned 2,962.55% to its investors. For the year ended December 31, 2024, Nutex Health (NASDAQ:NUTX) reported total revenue of $479.9 million, up 93.8% from 2023, driven largely by $169.7 million in arbitration-related revenue. The company achieved $130.6 million in operating income, a major turnaround from a $31.8 million loss the previous year, and posted net income of $52.2 million. Adjusted EBITDA soared to $123.7 million, up over 1,000% year-over-year, with hospital visits rising nearly 17% to 168,388. Nutex Health (NASDAQ:NUTX) is also one of the . Overall, NUTX ranks 3rd on our list of most expensive stocks insiders are buying after Trump's tariff rollout. While we acknowledge the potential of NUTX, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than NUTX but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
